InsiderSignal.AI

InsiderSignal.ai

TARS - Tarsus Pharmaceuticals, Inc.

Insider Sale by Lin Elizabeth Yeu (Chief Medical Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

6 days ago, Lin Elizabeth Yeu, serving as Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,144 shares at $68.36 per share, for a total transaction value of $78,204.00. Following this transaction, Lin Elizabeth Yeu now holds 41,708 shares of TARS.

This sale represents a 3.00% decrease in Lin Elizabeth Yeu's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Lin Elizabeth Yeu

Chief Medical Officer

Elizabeth Yeu-Lin, M.D. is the Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS), appointed effective November 4, 2024, after serving as a board director from December 2021 to November 2024 and as consulting Chief Medical Advisor since August 2020.[[1]](https://fintool.com/app/research/companies/TARS/people/elizabeth-yeu-lin)[[2]](https://modernod.com/news/tarsus-appoints-elizabeth-yeu-md-as-chief-medical-officer/2482527/)[[4]](https://www.marketscreener.com/insider/ELIZABETH-YEU-LIN-A31HOH/) A distinguished ophthalmologist with over two decades of experience, Dr. Yeu-Lin earned her medical degree through a 7-year combined undergraduate and medical honors program at the University of Florida College of Medicine, completed her ophthalmology residency (Chief Resident, 2006–2007) at Rush University Medical Center, and a fellowship in cornea/anterior segment/refractive surgery at Baylor College of Medicine’s Cullen Eye Institute.[[1]](https://fintool.com/app/research/companies/TARS/people/elizabeth-yeu-lin)[[2]](https://modernod.com/news/tarsus-appoints-elizabeth-yeu-md-as-chief-medical-officer/2482527/) She is a Partner at Virginia Eye Consultants since 2014, Assistant Professor of Ophthalmology at Eastern Virginia Medical School since 2012, and Immediate Past President of the American Society of Cataract and Refractive Surgery (ASCRS).[[1]](https://fintool.com/app/research/companies/TARS/people/elizabeth-yeu-lin)[[2]](https://modernod.com/news/tarsus-appoints-elizabeth-yeu-md-as-chief-medical-officer/2482527/)[[4]](https://www.marketscreener.com/insider/ELIZABETH-YEU-LIN-A31HOH/) Dr. Yeu-Lin serves on boards including STAAR Surgical (Chair since February 2025), Virginia Eye Foundation, and others, and has authored hundreds of publications on refractive cataract surgery, anterior segment reconstruction, and ocular disease management.[[1]](https://fintool.com/app/research/companies/TARS/people/elizabeth-yeu-lin)[[2]](https://modernod.com/news/tarsus-appoints-elizabeth-yeu-md-as-chief-medical-officer/2482527/)[[4]](https://www.marketscreener.com/insider/ELIZABETH-YEU-LIN-A31HOH/) In her CMO role, she leads Tarsus' medical organization, including medical affairs, pharmacovigilance, evidence generation, and patient safety, supporting products like XDEMVY for demodex blepharitis.[[2]](https://modernod.com/news/tarsus-appoints-elizabeth-yeu-md-as-chief-medical-officer/2482527/)[[3]](https://www.healthcare-brew.com/stories/2025/12/09/tarsus-pharmaceuticals-chief-medical-officer-ai-eye-care)

View full insider profile →

Trade Price

$68.36

Quantity

1,144

Total Value

$78,204.00

Shares Owned

41,708

Trade Date

Tuesday, March 17, 2026

6 days ago

SEC Filing Date

Thursday, March 19, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Tarsus Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning TARS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4923556

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime